Detailseite
Projekt Druckansicht

Role of soluble adenylyl cyclase in ischemia-reperfusion-induced brain injury

Fachliche Zuordnung Molekulare und zelluläre Neurologie und Neuropathologie
Förderung Förderung von 2010 bis 2015
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 165505620
 
Erstellungsjahr 2015

Zusammenfassung der Projektergebnisse

The results of the project demonstrate the novel role of sAC in cell death and growth (for review see publication 6 above). First, investigations with cultured neurons and cardiomyocytes provide convincing evidences that sAC significantly contributes to the hypoxia/anoxia and reoxygenation induced apoptotic cell death. Inhibition of sAC rescued the jeopardized neurons and cardiomyocytes. Although the mechanistic side of the sAC action is still incompletely understood, the involvement of mitochondrial pathway of apoptosis, and particularly sAC-PKA-dependent Bax phosphorylation, has been found. Second, aside of hypoxia/anoxia, sAC contribute to the smooth muscle cells apoptosis induced either by direct treatment with ROS or with oxysterols. Third, our findings demonstrate that sAC controls cell proliferation and radioresistance. sAC promotes cell growth and survival due to activation of EPAC-BRaf-ERK signaling. Therefore, sAC, as an alternative, intracellular localized source of cAMP, may play a controversial role regarding cell survival. The further investigation of the mechanistic part of sAC action is required to reveal the causes for the controversy. Nevertheless, these initial studies provide the basis for the development of new strategies for the treatment of diseases arising from the dysregulation of cell growth, such as cancer and cardiac hypertrophy, or from enhanced cell death, including neurodegenerative and ischemic diseases.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung